Tony Tang - Precision Back Pressure Regulators and more

Tony Tang

Engineering Manager

Zero Flow Patent

As Engineering Manager, Tony Tang’s responsibilities include design, quality system management, and broad-based consultation and support. Tony works closely with clients to understand their challenges and develop the best solution for their applications while ensuring quality product delivery. He is a member of Equilibar’s tactical leadership team.

“Typically, I gravitate to research applications where the user’s end goal is something unique and new to an industry or process,” he says. “I’m intrigued by how clients in all sorts of research backgrounds find clever ways to use Equilibar technology.”

Tony has eight years of experience at Equilibar and is one of the inventors named on the Zero Flow back pressure regulator patent. He is a knowledgeable resource for process control design and has a natural talent for managing large projects without missing the small details. His calm approach helps keep everyone productive. “I believe it’s important to try not to get frustrated with problems because the majority of our job here at Equilibar is trying to solve problems to get the client a solution.”

Away from work, Tony is active in multiple outdoor activities including rock climbing and mountain biking. He is involved with several conservation organizations in the region.

Tony’s areas of interest include catalysis, fuel cell technology, and core analysis. He earned B.S. and M.S. degrees in Mechanical Engineering from North Carolina State University.

Equilibar News

tokyo biopharma expo flow chemistry continuous manufacturing

Travel spotlight: Japan highlights opportunities in Flow Chemistry, Continuous Manufacturing, API

Earlier this summer, Equilibar engineers Ryan Heffner and Alan Black spent a productive week in Tokyo working with several of our Japanese customers and attending Biopharma Expo, a large pharmaceutical trade show. According to the U.S. Department of Commerce, Japan is one of the largest pharmaceutical markets in the world and it is continuing to Read More

Read More